In a filing, Cabaletta Bio Inc revealed its insider Binder Gwendolyn unloaded Company’s shares for reported $0.22 million on Jan 19 ’24. In the deal valued at $19.59 per share,11,000 shares were sold. As a result of this transaction, Binder Gwendolyn now holds 20,000 shares worth roughly $0.27 million.
Then, Binder Gwendolyn sold 11,000 shares, generating $240,789 in total proceeds. Upon selling the shares at $21.89, the insider now owns 20,000 shares.
Before that, Binder Gwendolyn sold 11,000 shares. Cabaletta Bio Inc shares valued at $196,014 were divested by the insider at a price of $17.82 per share. As a result of the transaction, Binder Gwendolyn now holds 20,000 shares, worth roughly $0.27 million.
Jefferies initiated its Cabaletta Bio Inc [CABA] rating to a Buy in a research note published on February 05, 2024; the price target was $36. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late November with a ‘”an Outperform”‘ rating. Cantor Fitzgerald began covering CABA with “an Overweight” recommendation on October 24, 2023. Stifel started covering the stock on October 19, 2023. It rated CABA as “a Buy”.
Price Performance Review of CABA
On Tuesday, Cabaletta Bio Inc [NASDAQ:CABA] saw its stock unchanged to $13.32. Over the last five days, the stock has lost -18.23%. Cabaletta Bio Inc shares have fallen nearly -41.32% since the year began. Nevertheless, the stocks have risen 55.06% over the past one year. While a 52-week high of $26.35 was reached on 02/08/24, a 52-week low of $7.69 was recorded on 04/22/24. SMA at 50 days reached $19.34, while 200 days put it at $17.27. A total of 0.76 million shares were traded, compared to the trading of 0.99 million shares in the previous session.
Levels Of Support And Resistance For CABA Stock
The 24-hour chart illustrates a support level at 13.07, which if violated will result in even more drops to 12.83. On the upside, there is a resistance level at 13.79. A further resistance level may holdings at 14.27. The Relative Strength Index (RSI) on the 14-day chart is 25.45, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.70, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.86%. Stochastics %K at 6.22% indicates the stock is a buying.
The most recent change occurred on September 05, 2023 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $22 price target.
